Back
CVE-2019-15931
CRITICAL
Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.
Published: Dec 12, 2019
Modified: Jun 17, 2026
CWE-22
CVSS Metrics
CVSSv3
Attack Vector:
NETWORK
Attack Complexity:
LOW
Privileges Required:
NONE
User Interaction:
NONE
Scope:
UNCHANGED
Confidentiality Impact:
HIGH
Integrity Impact:
HIGH
Availability Impact:
HIGH
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Affected Products (1)
| Vendor | Product | Version |
|---|---|---|
| intesync | solismed | 3.3 |
GitHub Security Advisory GHSA-hpf3-9554-j2mf
Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.
References (8)
- https://bishopfox.com Third Party Advisory
- https://know.bishopfox.com/advisories/solismed-critical Exploit, Third Party Advisory
- https://www.bishopfox.com/blog/news-category/advisories/ Third Party Advisory
- https://www.solismed.com/ Product
- https://bishopfox.com Third Party Advisory
- https://know.bishopfox.com/advisories/solismed-critical Exploit, Third Party Advisory
- https://www.bishopfox.com/blog/news-category/advisories/ Third Party Advisory
- https://www.solismed.com/ Product
Risk Scores
CVSS Score
9.8 / 10
EPSS Score
2.73%
Top 15% most likely to be exploited
Threat Score
40 / 100
Data Sources
NVD
EPSS
GitHub